Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial

Author:

Winchester Danyelle A.1ORCID,Till Cathee2,Goodman Phyllis J.2,Tangen Catherine M.2,Santella Regina M.3,Johnson-Pais Teresa L.4,Leach Robin J.4,Xu Jianfeng5ORCID,Zheng S. Lilly56,Thompson Ian M.4,Lucia M. Scott7,Lippman Scott M.8,Parnes Howard L.9,Isaacs William B.1011,De Marzo Angelo M.101112,Drake Charles G.10111314,Platz Elizabeth A.11011

Affiliation:

1. Department of Epidemiology; Johns Hopkins Bloomberg School of Public Health; Baltimore Maryland

2. SWOG Statistical Center; Fred Hutchinson Cancer Research Center; Seattle Washington

3. Department of Environmental Health Sciences; Mailman School of Public Health; Columbia University; New York New York

4. Department of Urology; University of Texas Health Science Center at San Antonio; San Antonio Texas

5. Program for Personalized Cancer Care and Department of Surgery; NorthShore University Health System; Evanston Illinois

6. Center for Cancer Genomics; Wake Forest University School of Medicine; Winston-Salem North Carolina

7. Department of Pathology; University of Colorado Denver School of Medicine; Aurora Colorado

8. Moores Cancer Center; University of California San Diego; La Jolla California

9. Division of Cancer Prevention; Department of Health and Human Services; National Cancer Institute; National Institutes of Health; Bethesda Maryland

10. James Buchanan Brady Urological Institute and Department of Urology; Johns Hopkins University School of Medicine; Baltimore Maryland

11. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Baltimore Maryland

12. Department of Pathology; Johns Hopkins University School of Medicine; Baltimore Maryland

13. Department of Immunology; Johns Hopkins University School of Medicine; Baltimore Maryland

14. Department of Oncology; Columbia University; New York New York

Funder

National Cancer Institute

Publisher

Wiley

Subject

Urology,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3